Leonard S. Schleifer

Insider Reports History

Entity
Individual
Location
777 Old Saw Mill River Road, Tarrytown, New York
Signature
/s/**Leonard S. Schleifer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Leonard S. Schleifer:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REGENERON PHARMACEUTICALS, INC. Bd. Co-Chair, President & CEO, Director Common Stock 466,877 $479 M $1,025.27 Jun 11, 2024 Direct
REGENERON PHARMACEUTICALS, INC. Bd. Co-Chair, President & CEO, Director Common Stock 157,552 $162 M $1,025.27 Jun 11, 2024 2023 GRAT
REGENERON PHARMACEUTICALS, INC. Bd. Co-Chair, President & CEO, Director Common Stock 39,985 $40.6 M $1,016.62 Jun 12, 2024 By Trust
REGENERON PHARMACEUTICALS, INC. Bd. Co-Chair, President & CEO, Director Common Stock 5,932 $6.08 M $1,025.27 Jun 11, 2024 By 401(k) Plan
REGENERON PHARMACEUTICALS, INC. Bd. Co-Chair, President & CEO, Director Common Stock 0 $0 $1,025.27 Jun 12, 2024 by Trust for Son
REGENERON PHARMACEUTICALS, INC. Bd. Co-Chair, President & CEO, Director Class A Stock 1,710,790 Jun 11, 2024 Direct
REGENERON PHARMACEUTICALS, INC. Bd. Co-Chair, President & CEO, Director Class A Stock 14,775 Jun 12, 2024 by Trust for Son
REGENERON PHARMACEUTICALS, INC. Bd. Co-Chair, President & CEO, Director 2019 Performance Stock Units 0 $844.09 Dec 11, 2023 Direct
REGENERON PHARMACEUTICALS, INC. Bd. Co-Chair, President & CEO, Director Non-Qualified Stock Option (right to buy) 0 May 13, 2024 Direct

Insider Reports Filed by Leonard S. Schleifer

Symbol Company Period Transactions Value $ Form Type Date Filed Role
REGN REGENERON PHARMACEUTICALS, INC. Jun 11, 2024 7 -25,610,229 4 Jun 13, 2024 Bd. Co-Chair, President & CEO, Director
REGN REGENERON PHARMACEUTICALS, INC. Jun 6, 2024 1 -798,821 4 Jun 10, 2024 Bd. Co-Chair, President & CEO, Director
REGN REGENERON PHARMACEUTICALS, INC. May 17, 2024 2 -22,355,714 4 May 17, 2024 Bd. Co-Chair, President & CEO, Director
REGN REGENERON PHARMACEUTICALS, INC. May 13, 2024 15 -95,075,310 4 May 15, 2024 Bd. Co-Chair, President & CEO, Director
REGN REGENERON PHARMACEUTICALS, INC. Dec 11, 2023 3 -10,838,960 4 Dec 13, 2023 Bd. Co-Chair, President & CEO, Director
REGN REGENERON PHARMACEUTICALS, INC. May 15, 2023 2 0 4 May 17, 2023 President & CEO, Director
REGN REGENERON PHARMACEUTICALS, INC. Apr 5, 2022 2 -5,051,269 4 Apr 7, 2022 President & CEO, Director
REGN REGENERON PHARMACEUTICALS, INC. Mar 31, 2022 1 -2,049,089 4 Apr 4, 2022 President & CEO, Director
REGN REGENERON PHARMACEUTICALS, INC. Nov 19, 2021 6 -119,112,839 4 Nov 19, 2021 President & CEO, Director
REGN REGENERON PHARMACEUTICALS, INC. Aug 18, 2021 2 -136,606,300 4 Aug 20, 2021 President & CEO, Director
REGN REGENERON PHARMACEUTICALS, INC. Aug 16, 2021 15 -6,243,614 4 Aug 17, 2021 President & CEO, Director
REGN REGENERON PHARMACEUTICALS, INC. Aug 6, 2021 8 -118,049,598 4 Aug 10, 2021 President & CEO, Director